---
title: "Cabozantinib - Medullary Thyroid Carcinoma"
sidebar: mydoc_sidebar
permalink: db08875-mesh-c536914-1.html
toc: false 
---


Path ID: `DB08875_MESH_C536914_1`
{% include image.html url="images/db08875-mesh-c536914-1.png" file="db08875-mesh-c536914-1.png" alt="db08875-mesh-c536914-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C558660 | Cabozantinib | Drug |
| UniProt:P08581 | Hepatocyte growth factor receptor | Protein |
| UniProt:P35968 | Vascular endothelial growth factor receptor 2 | Protein |
| UniProt:P07949 | Proto-oncogene tyrosine-protein kinase receptor Ret | Protein |
| GO:0007169 | Transmembrane receptor protein tyrosine kinase signaling pathway | BiologicalProcess |
| GO:0001525 | Angiogenesis | BiologicalProcess |
| HP:0031377 | Abnormal cell proliferation | PhenotypicFeature |
| MESH:C536914 | Medullary thyroid carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cabozantinib | DECREASES ACTIVITY OF | Hepatocyte Growth Factor Receptor |
| Cabozantinib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor 2 |
| Cabozantinib | DECREASES ACTIVITY OF | Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret |
| Hepatocyte Growth Factor Receptor | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Vascular Endothelial Growth Factor Receptor 2 | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret | POSITIVELY REGULATES | Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway |
| Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway | POSITIVELY CORRELATED WITH | Angiogenesis |
| Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Angiogenesis | OCCURS IN | Medullary Thyroid Carcinoma |
| Abnormal Cell Proliferation | OCCURS IN | Medullary Thyroid Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08875#BE0000915](https://go.drugbank.com/drugs/DB08875#BE0000915)
  - [https://en.wikipedia.org/wiki/Cabozantinib](https://en.wikipedia.org/wiki/Cabozantinib)
